Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Cresco Labs Inc.
  6. Financials
    CRLBF   CA22587M1068

CRESCO LABS INC.

(CRLBF)
  Report
Delayed OTC Markets  -  01:17 2022-08-10 pm EDT
3.545 USD   +0.42%
08/09Cresco Labs - Illinois Begins Issuing New Adult-Use Dispensary Licenses; Recipients Include Social Equity Groups Incubated by Cresco Labs' SEED Initiative
AQ
08/08Illinois Begins Issuing New Adult-Use Dispensary Licenses; Recipients Include Social Equity Groups Incubated by Cresco Labs' SEED™ Initiative
BU
08/01Cresco Labs to Hold Second Quarter 2022 Earnings Conference Call on August 17, 2022
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 9402 3431 9291 083--
Enterprise Value (EV)2 8912 3912 1911 4671 3921 266
P/E ratio -17,2x-25,6x-5,50x-124x32,2x12,1x
Yield ------
Capitalization / Revenue 7,31x4,92x2,35x1,20x0,97x0,69x
EV / Revenue 6,93x5,02x2,67x1,63x1,24x0,80x
EV / EBITDA 112x20,6x11,3x6,69x4,71x3,03x
Price to Book 4,04x3,66x2,33x1,34x1,23x1,10x
Nbr of stocks (in thousands) 136 840237 757290 734304 588--
Reference price (CAD) 8,9312,68,394,584,584,58
Announcement Date 04/27/202003/25/202103/23/2022---
1 CAD in Million
2 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 1294768229021 1191 578
EBITDA1 7,99116194219295417
Operating profit (EBIT)1 -34,355,8-217129229387
Operating Margin -26,7%11,7%-26,5%14,3%20,4%24,5%
Pre-Tax Profit (EBT)1 -50,87,16-25762,5167378
Net income1 -43,2-81,9-297-21,744,085,7
Net margin -33,6%-17,2%-36,1%-2,40%3,93%5,43%
EPS2 -0,52-0,49-1,52-0,040,140,38
Dividend per Share ------
Announcement Date 04/27/202003/25/202103/23/2022---
1 USD in Million
2 CAD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 215218214218229239
EBITDA1 56,457,050,751,356,561,0
Operating profit (EBIT)1 -26415,620,330,234,939,8
Operating Margin -123%7,14%9,45%13,8%15,3%16,7%
Pre-Tax Profit (EBT)1 -27611,6-0,8715,118,922,7
Net income1 -271-11,9-23,7-0,56-0,145,95
Net margin -126%-5,47%-11,0%-0,26%-0,06%2,49%
EPS2 -1,26-0,04-0,12-0,01-0,02
Dividend per Share ------
Announcement Date 11/11/202103/23/202205/18/2022---
1 USD in Million
2 CAD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 -48,2261385309183
Net Cash position1 49,1-----
Leverage (Debt / EBITDA) -6,15x0,42x1,35x1,75x1,05x0,44x
Free Cash Flow1 -117-89,1-79,42,04102-13,1
ROE (Net Profit / Equities) -7,48%-13,8%2,23%1,10%10,9%-
Shareholders' equity1 577593-13 306-1 971405-
ROA (Net Profit / Asset) -11,5%-5,39%0,91%0,50%5,70%-
Assets1 3741 519-32 626-4 337771-
Book Value Per Share2 2,213,433,603,413,734,18
Cash Flow per Share -0,30-0,06----
Capex1 91,778,393,987,071,3105
Capex / Sales 71,3%16,4%11,4%9,64%6,37%6,66%
Announcement Date 04/27/202003/25/202103/23/2022---
1 USD in Million
2 CAD
Previous periodNext period
Estimates
Key data
Capitalization (CAD) 1 395 012 998
Capitalization (USD) 1 082 748 369
Net sales (USD) 821 682 000
Number of employees 3 600
Sales / Employee (USD) 228 245
Free-Float 52,0%
Free-Float capitalization (CAD) 725 792 471
Free-Float capitalization (USD) 563 328 524
Avg. Exchange 20 sessions (USD) 1 590 273
Average Daily Capital Traded 0,11%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA